Thermo Fisher Scientific Inc. (TMO)

NYSE: TMO · Real-Time Price · USD

576.41

+16.88 (3.02%)

At close: Jul 28, 2026, 4:00 PM EDT

580.00

+3.59 (0.62%)

After-hours: Jul 28, 2026, 7:15 PM EDT

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Jun '26 Jun 27, 2026	Mar '26 Mar 28, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 27, 2025	Jun '25 Jun 28, 2025	Mar '25 Mar 29, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 28, 2024	Jun '24 Jun 29, 2024	Mar '24 Mar 30, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jul '23 Jul 1, 2023	Apr '23 Apr 1, 2023	Dec '22 Dec 31, 2022	Oct '22 Oct 1, 2022	Jul '22 Jul 2, 2022	Apr '22 Apr 2, 2022	Dec '21 Dec 31, 2021	Oct '21 Oct 2, 2021	Jul '21 Jul 3, 2021	Apr '21 Apr 3, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 26, 2020
Life Sciences Solutions Revenue	2.82B
Analytical Instruments Revenue	1.85B
Specialty Diagnostics Revenue	1.21B
Laboratory Products and Biopharma Services Revenue	6.69B
Revenue (Other)	-566.00M
Revenue (Total)	11.99B

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Jun '26 Jun 27, 2026	Mar '26 Mar 28, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 27, 2025	Jun '25 Jun 28, 2025	Mar '25 Mar 29, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 28, 2024	Jun '24 Jun 29, 2024	Mar '24 Mar 30, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jul '23 Jul 1, 2023	Apr '23 Apr 1, 2023	Dec '22 Dec 31, 2022	Oct '22 Oct 1, 2022	Jul '22 Jul 2, 2022	Apr '22 Apr 2, 2022	Dec '21 Dec 31, 2021	Oct '21 Oct 2, 2021	Jul '21 Jul 3, 2021	Apr '21 Apr 3, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 26, 2020
Life Sciences Solutions Operating Income	1.04B
Analytical Instruments Operating Income	424.00M
Specialty Diagnostics Operating Income	334.00M
Laboratory Products and Biopharma Services Operating Income	936.00M
Operating Income (Other)	-648.00M
Operating Income (Total)	2.09B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Jun '26 Jun 27, 2026	Mar '26 Mar 28, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 27, 2025	Jun '25 Jun 28, 2025	Mar '25 Mar 29, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 28, 2024	Jun '24 Jun 29, 2024	Mar '24 Mar 30, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jul '23 Jul 1, 2023	Apr '23 Apr 1, 2023	Dec '22 Dec 31, 2022	Oct '22 Oct 1, 2022	Jul '22 Jul 2, 2022	Apr '22 Apr 2, 2022	Dec '21 Dec 31, 2021	Oct '21 Oct 2, 2021	Jul '21 Jul 3, 2021	Apr '21 Apr 3, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 26, 2020
Total Organic Revenue Growth	5.00%